Atherogenic index of plasma combined with waist circumference and body mass index to predict metabolic-associated fatty liver disease

doi:10.3748/wjg.v28.i36.5364

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 36

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2938)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-6) series.

Item

Count

PDF

191

WORD

HTML

1800

Figures (1-6)

226

Tables (1-6)

203

Sum=2455

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

192

Download

291

Sum=483

Sep 28, 2022 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Sep 28, 2022; 28(36): 5364-5379
Published online Sep 28, 2022. doi: 10.3748/wjg.v28.i36.5364

Table 1 Baseline characteristics of the study subjects

Variable	Non-MAFLD, n = 352	MAFLD, n = 512	Statistics¹	P value
Demographics
Sex			χ² = 14.020	< 0.001
Male	230 (65.3)	394 (77.0)
Female	122 (34.7)	118 (23.0)
Age in yr	37.750 ± 10.736	41.240 ± 10.852	t = -4.634	< 0.001
Age ≥ 40 yr	115 (32.7)	254 (49.6)	χ² = 24.461	< 0.001
Age < 40 yr	237 (67.3)	258 (40.4)
Smoking history	81 (23.0)	174 (34.0)	χ²= 12.073	< 0.001
Drinking history	76 (21.6)	145 (28.3)	χ²= 4.962	0.027
Anthropometrics
WC in cm	86.240 ± 9.893	96.790 ± 8.618	t = -16.219	< 0.001
BMI in kg/m²	24.436 ± 3.169	28.028 ± 3.221	t = -16.228	< 0.001
SBP in mmHg	125.880 ± 14.883	133.610 ± 16.859	t = -6.908	< 0.001
DBP in mmHg	77.500 ± 11.658	82.950 ± 12.525	t = -6.461	< 0.001
Laboratory tests
ALT in U/L	21.0 (15.0, 30.0)	34.0 (24.0, 54.0)	Z = -12.276	< 0.001
AST in U/L	19.0 (17.0, 23.0)	23.0 (19.0, 29.0)	Z = -9.058	< 0.001
TC in mmol/L	4.539 ± 0.847	4.783 ± 0.902	t = -4.104	< 0.001
TG in mmol/L	1.1 (0.7, 1.5)	1.8 (1.3, 2.6)	Z = -13.650	< 0.001
HDL-C in mmol/L	1.351 ± 0.283	1.191 ± 0.256	t = 8.321	< 0.001
LDL-C in mmol/L	2.645 ± 0.708	2.906 ± 0.884	t = -4.568	< 0.001
FBG in mmol/L	5.2 (4.9, 5.4)	5.4 (5.1, 5.9)	Z = -7.637	< 0.001
SUA in μmol/L	332.722 ± 86.289	377.836 ± 85.859	t = -7.590	< 0.001
AIP	-0.11 (-0.30, 0.08)	0.20 (0.03, 0.39)	Z = -14.006	< 0.001

¹Comparison of significant differences between the two groups; χ² value calculated by the χ² test; Z value calculated by the Mann-Whitney U test; t value calculated by the independent samples t test. Data are presented as median and interquartile range, mean and standard deviation or frequency (percentage). MAFLD: Metabolic-associated fatty liver disease; WC: Waist circumference; BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; TC: Total cholesterol; TG: Triglyceride; HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol; FBG: Fasting blood glucose; SUA: Serum uric acid; AIP: Atherogenic index of plasma.

Citation: Duan SJ, Ren ZY, Zheng T, Peng HY, Niu ZH, Xia H, Chen JL, Zhou YC, Wang RR, Yao SK. Atherogenic index of plasma combined with waist circumference and body mass index to predict metabolic-associated fatty liver disease. World J Gastroenterol 2022; 28(36): 5364-5379
URL: https://www.wjgnet.com/1007-9327/full/v28/i36/5364.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i36.5364